Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-08-30 03:32 | 2018-08-27 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | SALE | $130.38 | 7,500 | $977,825 | 57,787 | -11.5% |
| 2018-08-23 02:20 | 2018-08-20 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | OPT+S | $125.05 | 7,500 | $937,853 | 65,287 | -10.3% |
| 2018-07-31 03:24 | 2018-07-26 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | OPT+S | $144.43 | 7,500 | $1,083,243 | 65,287 | -10.3% |
| 2018-07-24 02:00 | 2018-07-19 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | OPT+S | $139.92 | 7,500 | $1,049,415 | 65,287 | -10.3% |
| 2018-01-19 01:51 | 2018-01-16 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | OPT+S | $88.80 | 30,000 | $2,664,012 | 24,098 | -55.5% |
| 2017-08-04 01:00 | 2017-08-01 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; See Remarks | Surgical & Medical Instruments & Apparatus | OPT+S | $79.42 | 32,000 | $2,541,386 | 42,500 | -43.0% |
| 2017-02-15 02:54 | 2017-02-10 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | OPT+S | $71.93 | 2,200 | $158,241 | 43,941 | -4.8% |
| 2017-02-10 03:43 | 2017-02-07 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | OPT+S | $70.31 | 7,724 | $543,110 | 43,941 | -15.0% |
| 2017-02-07 04:53 | 2017-02-02 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $69.96 | 5,808 | $406,326 | 45,241 | -11.4% |
| 2017-02-02 03:55 | 2017-01-30 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $71.00 | 7,298 | $518,144 | 51,049 | -12.5% |
| 2017-01-28 04:29 | 2017-01-25 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $74.25 | 10,970 | $814,564 | 58,347 | -15.8% |
| 2016-09-07 04:11 | 2016-09-01 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $70.81 | 17,600 | $1,246,208 | 44,126 | -28.5% |
| 2016-09-01 04:38 | 2016-08-29 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $71.19 | 5,300 | $377,303 | 61,726 | -7.9% |
| 2016-08-30 03:51 | 2016-08-25 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $71.03 | 5,300 | $376,434 | 67,026 | -7.3% |
| 2016-08-25 04:48 | 2016-08-22 | PEN | Penumbra Inc | Davis Daniel Donen | Officer; President, North America | Surgical & Medical Instruments & Apparatus | SALE | $72.97 | 6,300 | $459,727 | 72,326 | -8.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.